These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 18628561)

  • 21. Atovaquone + proguanil: new indication. For children weighing as little as 5 kg; an inconvenient form. A flavoured syrup would be better suited to infants and young children.
    Prescrire Int; 2009 Jun; 18(101):113. PubMed ID: 19637424
    [No Abstract]   [Full Text] [Related]  

  • 22. [Tolerance and efficacy of atovaquone-proguanil for the treatment of paediatric imported Plasmodium falciparum malaria in France: clinical practice in a university hospital in Paris].
    Blondé R; Naudin J; Bigirimana Z; Holvoet L; Fenneteau O; Vitoux C; Bourdon O; Angoulvant F; Lorrot M; D'Ortenzio E; Bourrillon A; Le Bras J; Matheron S; Faye A
    Arch Pediatr; 2008 Mar; 15(3):245-52. PubMed ID: 18321692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic confirmation of atovaquone-proguanil-resistant Plasmodium falciparum malaria acquired by a nonimmune traveler to East Africa.
    Schwartz E; Bujanover S; Kain KC
    Clin Infect Dis; 2003 Aug; 37(3):450-1. PubMed ID: 12884171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atovaquone and proguanil hydrochloride: a review of nonclinical studies.
    Pudney M; Gutteridge W; Zeman A; Dickins M; Woolley JL
    J Travel Med; 1999 May; 6 Suppl 1():S8-12. PubMed ID: 23573546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prolonged protection provided by a single dose of atovaquone-proguanil for the chemoprophylaxis of Plasmodium falciparum malaria in a human challenge model.
    Deye GA; Miller RS; Miller L; Salas CJ; Tosh D; Macareo L; Smith BL; Fracisco S; Clemens EG; Murphy J; Sousa JC; Dumler JS; Magill AJ
    Clin Infect Dis; 2012 Jan; 54(2):232-9. PubMed ID: 22052893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phototoxic reaction associated with Malarone (atovaquone/proguanil) antimalarial prophylaxis.
    Amelot A; Dupouy-Camet J; Jeanmougin M
    J Dermatol; 2014 Apr; 41(4):346-8. PubMed ID: 24612343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Failure of atovaquone/proguanil to prevent Plasmodium ovale malaria in traveler returning from Cameroon.
    Gallien S; Taieb F; Schlemmer F; Lagrange-Xelot M; Atlan A; Sarfati C; Molina JM
    Travel Med Infect Dis; 2008 May; 6(3):128-9. PubMed ID: 18486067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Fluindione and falciparum malaria treated by atovaquone-proguanil].
    Kamaliddin C; Joste V; Argy N; Houzé S
    Therapie; 2018 Oct; 73(5):445-447. PubMed ID: 29680373
    [No Abstract]   [Full Text] [Related]  

  • 29. [Mechanism of action of antimalarials. Value of combined atovaquone/proguanil].
    Touze JE; Fourcade L; Pradines B; Hovette P; Paule P; Heno P
    Med Trop (Mars); 2002; 62(3):219-24. PubMed ID: 12244914
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in nonimmune pediatric travelers: results of an international, randomized, open-label study.
    Camus D; Djossou F; Schilthuis HJ; Høgh B; Dutoit E; Malvy D; Roskell NS; Hedgley C; De Boever EH; Miller GB;
    Clin Infect Dis; 2004 Jun; 38(12):1716-23. PubMed ID: 15227617
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Failure of atovaquone-proguanil malaria chemoprophylaxis in a traveler to Ghana.
    Boggild AK; Lau R; Reynaud D; Kain KC; Gerson M
    Travel Med Infect Dis; 2015; 13(1):89-93. PubMed ID: 25582377
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [New strategies in therapy to roll back malaria].
    Kaiser A; Maier W
    Dtsch Med Wochenschr; 2002 Jul; 127(30):1595-600. PubMed ID: 12143016
    [No Abstract]   [Full Text] [Related]  

  • 33. [Malarone: newcomer in the treatment of malaria].
    Touze JE; Fourcade L
    Med Trop (Mars); 1997; 57(3):225-7. PubMed ID: 9513142
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical pharmacology of atovaquone and proguanil hydrochloride.
    Beerahee M
    J Travel Med; 1999 May; 6 Suppl 1():S13-7. PubMed ID: 23573547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Malarone: a new antimalarial for malaria chemoprevention].
    Delmont J
    Med Trop (Mars); 2002; 62(1):19-21. PubMed ID: 12038171
    [No Abstract]   [Full Text] [Related]  

  • 36. Ketoconazole increases atovaquone exposure following concomitant administration with Malarone® in healthy subjects.
    Thapar MM; Ursing J; Ashton M; Bergqvist Y; Gil JP; Björkman A
    J Travel Med; 2022 Jul; 29(4):. PubMed ID: 35532299
    [No Abstract]   [Full Text] [Related]  

  • 37. Early treatment failure during treatment of Plasmodium falciparum malaria with atovaquone-proguanil in the Republic of Ivory Coast.
    Wurtz N; Pascual A; Marin-Jauffre A; Bouchiba H; Benoit N; Desbordes M; Martelloni M; Pommier de Santi V; Richa G; Taudon N; Pradines B; Briolant S
    Malar J; 2012 May; 11():146. PubMed ID: 22551095
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Post-malaria neurological syndrome complicating a relapse of Plasmodium falciparum malaria after atovaquone-proguanil treatment].
    Forestier E; Labe A; Raffenot D; Lecomte C; Rogeaux O
    Med Mal Infect; 2011 Jan; 41(1):41-3. PubMed ID: 20800398
    [No Abstract]   [Full Text] [Related]  

  • 39. Cytogenetic and oxidative status of human lymphocytes after exposure to clinically relevant concentrations of antimalarial drugs atovaquone and proguanil hydrochloride in vitro.
    Dinter D; Gajski G; Domijan AM; Garaj-Vrhovac V
    Fundam Clin Pharmacol; 2015 Dec; 29(6):575-85. PubMed ID: 26434663
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasmodium falciparum outwits Malarone, protector of travellers.
    Crabb C
    Bull World Health Organ; 2003; 81(5):382-3. PubMed ID: 12856058
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.